Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Arginase inhibitor 1 is a potent inhibitor of human arginases I and II (IC50s: 223 and 509 nM).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,670 | 35日内发货 | ||
5 mg | ¥ 11,900 | 35日内发货 |
产品描述 | Arginase inhibitor 1 is a potent inhibitor of human arginases I and II (IC50s: 223 and 509 nM). |
靶点活性 | Arginases II:509 nM , Arginases I:223 nM |
体外活性 | Arginase inhibitor 1 is an arginase inhibitor with significant activity in a rat model of myocardial ischemia/reperfusion injury (MI/RI). Arginase inhibitor 1 is potent against hARG I in both in vitro enzyme and cellular assays. The IC50 for Arginase inhibitor 1 is 8 μM in CHO Cells Over-Expressing hArgI |
体内活性 | Pharmacokinetic evaluation of Arginase inhibitor 1 is conducted after intravenous (i.v.) and oral (p.o.) dosing in male Sprague-Dawley rats (n=3 per dose route). Arginase inhibitor 1 is formulated in 0.9% saline and administered intravenously at 10 mg/kg by bolus through a pre-implanted cannula at a dosing volume of 1 mL/kg, and orally at 10 mg/kg via gavage at a dosing volume of 2 mL/kg. Following i.v. dosing with 10 mg/kg in fasted animals, Arginase inhibitor 1has a terminal elimination half-life (t1/2) of 3.3 h with a volume of distribution and total body clearance of 1.86 L/kg and 7.89 mL/min/kg, respectively. The oral bioavailability of Arginase inhibitor 1 (10 mg/kg, p.o.) is 28% with a Cmax of 0.45 mg/L. |
分子量 | 286.18 |
分子式 | C13H27BN2O4 |
CAS No. | 1345808-25-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 30 mg/mL (104.83 mM)
DMSO: 48 mg/mL (167.73 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.4943 mL | 17.4715 mL | 34.943 mL | 87.3576 mL |
5 mM | 0.6989 mL | 3.4943 mL | 6.9886 mL | 17.4715 mL | |
10 mM | 0.3494 mL | 1.7472 mL | 3.4943 mL | 8.7358 mL | |
20 mM | 0.1747 mL | 0.8736 mL | 1.7472 mL | 4.3679 mL | |
50 mM | 0.0699 mL | 0.3494 mL | 0.6989 mL | 1.7472 mL | |
100 mM | 0.0349 mL | 0.1747 mL | 0.3494 mL | 0.8736 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Arginase inhibitor 1 1345808-25-4 Others Inhibitor inhibitor inhibit